Chemiluminescence sandwich enzyme immunoassay for determination of human granulocyte colony stimulating factor (G-CSF)
β Scribed by Aoyagi, Shigeo ;Arasawa, Kazue ;Matsuyuki, Akira ;Kamatchi, Shin-ichi ;Fukushima, Masafumi ;Ohsawa, Nakaaki
- Publisher
- John Wiley and Sons
- Year
- 1995
- Weight
- 432 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0884-3996
No coin nor oath required. For personal study only.
β¦ Synopsis
A chemiluminescence sandwich enzyme immunoassay, using a glucose oxidase (GO) label, was developed for detecting attomole amounts o f human granulocyte colony stimulating factor (G-CSF). Purified goat F(ab')* immobilized on a bead and purified goat Fab' labelled with GO were selected in combination w i t h a chemiluminescent detection system comprising luminol and ferricyanide. The detection limits for G-CSF were 4amol/assay (1 pg/mL) in buffer solution and lOamol/assay (2.5 pg/mL) in human serum. Coefficients o f variation within assay and between assay ranged from 5.5% t o 7.8% and from 3.4% t o 16.0%. respectively. The G-CSF content of serum from normal healthy individuals was measurable using this method. G-CSF in 24 normal human sera showed a mean value o f 19.3pg/mL and ranged from 3.6 t o 83.0 pg/mL.
π SIMILAR VOLUMES
We previously suggested that using a combined conditioning regimen including rhG-CSF with allogeneic BMT in refractory AML and CML in blast crisis might reduce the rate of relapse and improve disease-free survival, without any major side effects. In this study, we used the same protocol for 10 AML p
It has been reported previously that cells of the murine myelomonocytic leukaemia cell line WEH13B(D+) can be induced to differentiate into mature monocytes by incubation with post-endotoxin serum (ES), granulocyte-colony-stimulating factor (G-CSF) or actinomycin D (AMD). We have investigated the ki
Limited evidence suggests increased efficacy of rhG-CSF by subcutaneous (SQ) compared with intravenous (IV) administration. To examine the possibility that rapid elimination of IV rhG-CSF could substantially shorten the duration of systemic exposure and could explain a difference in pharmacodynamics
In a multi-centre phase I study we investigated the possibility of reducing the interval between courses of standard CHOP (cyclophosphamide 750 mg/m2, doxorubicin 50 mg/m', vincristine 2 mgs day 1, and prednisolone 40mglm' days 1-8) from 21 days to 15 days and then 10 days using granulocyte colony s